Gao Ruonan

Dr. Gao Ruonan

Fujian Medical University Union Hospital, Fuzhou, Fujian, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
MZMengjun Zhang
Mengjun Zhang
YWYubin Wu
Yubin Wu
GRGao Ruonan
Gao Ruonan
XCXinwei Chen
Xinwei Chen
RCRuiyu Chen
Ruiyu Chen
ZCZhou Chen
Zhou Chen

1 April 2021 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
GRGao Ruonan
Gao Ruonan
LRLingjia Ren
Lingjia Ren
YZYu Zhou
Yu Zhou
LWLijing Wang
Lijing Wang
YXYunzhen Xie
Yunzhen Xie
LLLibin Liu
Libin Liu

17 August 2022 in NeuroToxicology
Verified
Journal Article
Closed access
LQLiqin Qi
Liqin Qi
GRGao Ruonan
Gao Ruonan
ZCZhou Chen
Zhou Chen
DLDonghai Lin
Donghai Lin
ZLZhiqing Liu
Zhiqing Liu
LLLibin Liu
Libin Liu

3 November 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
XHXi He
Xi He
GRGao Ruonan
Gao Ruonan
YWYubin Wu
Yubin Wu
KWKejun Wu
Kejun Wu
JSjianmin Sun
jianmin Sun
LCLianglong Chen
Lianglong Chen
This is an observational, retrospective, single-center study aimed to determine whether the free triiodothyronine (FT3) to free thyroxine (FT4) ratio was related to acute myocardial infarction (AMI) prognosis in individuals with type 2 diabetes mellitus (T2DM). A total of 294 euthyroid T2DM patients with new-onset AMI were enrolled. FT3/FT4 ratio tertiles were used to categorize patients into Group 1 (FT3/FT4 ≥ 4.3), Group 2 (3.5 ≤ FT3/FT4 < 4.3), and Group 3 (FT3/FT4 < 3.5). Major adverse cardiac events (MACE), including nonfatal myocardial infarction, target vessel revascularization (TVR), and cardiac mortality, served as the primary endpoint. Group 3 demonstrated a considerably higher incidence of MACE than the other two groups over the average follow-up duration of 21 ± 6.5 months (all p < 0.001). Multivariable Cox regression analysis showed that a low FT3/FT4 ratio was an independent risk factor for MACE after AMI (Group 1 as a reference; Group 2: hazard ratio [HR] 1.275, 95% confidence interval [CI]: 0.563–2.889, p = 0.561; Group 3: HR 2.456, 95% CI: 1.105–5.459, p = 0.027). Moreover, the area under the receiver-operating characteristic curve (AUC) indicates a good predictive value of FT3/FT4 ratio for MACE (AUC = 0.70). Therefore, in T2DM patients with AMI, a low FT3/FT4 ratio was strongly linked to poor prognosis.

15 May 2026 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
XHXi He
Xi He
GHGuanlian He
Guanlian He
LQLiqin Qi
Liqin Qi
YCYujie Chen
Yujie Chen
ZLZhaorong Lin
Zhaorong Lin
GRGao Ruonan
Gao Ruonan
Background: The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) is a novel, reliable indicator of dyslipidemia. However, its association with cardiac outcomes in patients with type 2 diabetes mellitus (T2DM) following percutaneous coronary intervention (PCI) remains unclear. We investigated the association of the NHHR with the risks of major adverse cardiovascular events (MACEs) following PCI in adults with T2DM. Methods: This retrospective cohort study included 1176 adults with T2DM undergoing PCI after new-onset acute myocardial infarction between January 1, 2019, and December 31, 2023. Patients were categorized into NHHR quartiles. The relationship between the NHHR and post-PCI MACE risk was investigated using univariate and multivariate Cox regression analyses. Restricted cubic splines and smooth curve fitting evaluated the nonlinear association between the NHHR and MACE risk; receiver operating characteristic (ROC) curves determined the prognostic significance of the NHHR. Results: Over 21.0 ± 6.6 months, 246 MACEs occurred. In multivariate analysis, the NHHR was associated with MACE incidence, even after adjustments (vs. group Q1: hazard ratio [95% confidence interval] in groups Q3 and Q4, 4.00 [2.47–6.48] and 6.28 [3.92–10.05], respectively; both P < 0.05). The NHHR and MACEs were non-linearly related. Within the threshold of 3.12–5.10, every 1-unit rise in the NHHR elevated the MACE risk 1.4-fold. The area under the ROC curve of the NHHR combined with the Global Registry of Acute Coronary Events risk score was 0.84 for predicting post-PCI MACEs (sensitivity, 71.54%; specificity, 83.86%). The NHHR/MACE association persisted in subgroup analysis. No significant interactive effects were found for age, sex, hypertension, smoking, body mass index, glycated hemoglobin, and medications (P for interaction > 0.05). Conclusions: Our findings suggested a nonlinear positive association between NHHR and MACE risk in T2DM patients undergoing PCI. Routine NHHR assessment may facilitate early risk identification and tailored care for these patients.